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Krisztina Takács-VellaiAbstract
NM23-H1 (also known as NME1) was the first identified metastasis suppressor, which displays a nucleoside diphosphate
kinase (NDPK) and histidine protein kinase activity. NDPKs are linked to many processes, such as cell migration,
proliferation, differentiation, but the exact mechanism whereby NM23-H1 inhibits the metastatic potential of
cancer cells remains elusive. However, some recent data suggest that NM23-H1 may exert its anti-metastatic
effect by blocking Ras/ERK signaling. In mammalian cell lines NDPK-mediated attenuation of Ras/ERK signaling
occurs through phosphorylation (thus inactivation) of KSR (kinase suppressor of Ras) scaffolds. In this review I
summarize our knowledge about KSR’s function and its regulation in mammals and in C. elegans. Genetic studies
in the nematode contributed substantially to our understanding of the function and regulation of the Ras pathway
(i.e. KSR’s discovery is also linked to the nematode). Components of the RTK/Ras/ERK pathway seem to be highly
conserved between mammals and worms. NDK-1, the worm homolog of NM23-H1 affects Ras/MAPK signaling at the
level of KSRs, and a functional interaction between NDK-1/NDPK and KSRs was first demonstrated in the worm in vivo.
However, NDK-1 is a factor, which is necessary for proper MAPK activation, thus it activates rather than suppresses Ras/
MAPK signaling in the worm. The contradiction between results in mammalian cell lines and in the worm regarding
NDPKs’ effect exerted on the outcome of Ras signaling might be resolved, if we better understand the function,
structure and regulation of KSR scaffolds.
Keywords: Metastasis inhibitor, Nm23, Nucleoside-diphosphate kinase (NDPK), Kinase, Ras/ERK signaling, Kinase
suppressor of Ras (KSR), ScaffoldReview
Introduction
nm23-H1, also known as nme1, was the first identified
metastasis suppressor gene [1]. The reverse correlation be-
tween NM23 expression and metastatic potential had been
reported many times using cell lines and xenograft models
(reviewed in [2]). The metastasis inhibitor effect was also
demonstrated using mouse models: double transgenic mice
derived from a cross of nm23-M1 knockout mice with a
mouse strain prone to hepatocellular carcinoma show a
higher incidence of lung metastases [3]. Members of the
nme gene family encode nucleoside diphosphate kinases
(NDPK) [4]. In recent years NDPKs have been ascribed nu-
merous roles in development that are inconsistent with a
simple housekeeping role of balancing pools of nucleoside
diphosphates and triphosphates. Recent data suggest thatCorrespondence: takacsve@gmail.com
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unless otherwise stated.members of the nm23 family display multiple functions in
diverse biological processes such as signal transduction,
growth control, differentiation, cell migration, cancer pro-
motion [5-7]. Although the exact molecular process by
which NM23 inhibits the metastatic potential of cancer
cells is unknown, some molecular mechanisms have been
proposed to explain its anti-metastatic activity. NM23
silencing in hepatoma and colon carcinoma cell lines re-
sulted in upregulation of the membrane associated matrix
metalloproteinase (MT1-MMP), increased Rac1 signaling
and activation of several pro-invasive signaling pathways
such as MAPK (mitogen activated protein kinase)/SAPK
(stress-activated protein kinases), Akt [8]. Elevated Rac1
level upon NM23 knockdown suggests that NM23 inhibits
Rac1 activation. Although the exact mechanism is un-
known, NM23-H1 was shown to interact with factors in-
volved in Rac1 activation, such as the small GTPase Arf6
or the nucleotide exchange factor Tiam1 [9,10]. ARF6 by
recruiting NM23-H1 was reported to facilitate dynamin-Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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bly and NM23-H1 was suggested to provide a source of
GTP for ARF6 [9]. The highly specific functional relation-
ship between dynamin and the NM23 homolog AWD in
endocytosis was demonstrated by genetic studies in Dros-
ophila [11]. AWD functions as a negative regulator of cell
migration in tracheal and border cells by downregulating
receptor levels on the cell surface through dynamin-
mediated endocytosis [12,13], thus it suppresses cell motil-
ity through receptor internalization. Some studies suggest
that NM23-H1/H2 may exert its anti-metastatic effect by
blocking Ras/ERK (extracellular signal-regulated kinase)
signaling [14-17]. In this review I summarize how NM23-
H1 inhibits the Ras/ERK cascade in human cell lines, and
examine how the NM23 homolog NDK-1 modifies the
outcome of Ras signaling in the model organism Caenor-
habditis elegans [18].
The RTK/Ras/ERK pathway: its human relevance and
significance during nematode development
RTK (receptor tyrosine kinase)/Ras/ERK signaling plays a
critical role in a wide range of biological processes such as
cell proliferation and differentiation, cell migration and
survival, cellular metabolism (reviewed in [19]). Mutations
affecting RTK/Ras/ERK signaling cause human syndromes
called rasopathies, including Noonan syndrome, Costello
syndrome [20] and tumorigenesis [21].
RTKs often signal to the Ras/ERK cascade via GRB-2
(growth factor receptor-bound protein 2) and the Guanine
Nucleotide Exchange Factor (GEF) Sos (son of sevenless)
to activate the small GTPase Ras. Subsequently Ras-GTP
binds to Raf and promotes its association with the plasma
membrane and/or endomembranes [22], where Raf activa-
tion occurs. The scaffold protein KSR (kinase suppressor
of Ras) helps in Raf activation, but also contributes to the
sequential phosphorylation steps of the MAPK cascade by
bringing together MAPK components, Raf, MEK and
ERK/MAPK. Sequential phosphorylation within the MAPK
modul leads to ERK activation, which often results in
changes in gene expression [23].
Canonical RTK/Ras/ERK pathway plays multiple biological
roles during C. elegans development
Studies in the nematode Caenorhabditis elegans contrib-
uted substantially to our knowledge about the mechan-
ism and biological function of the canonical RTK/Ras/
ERK pathway. Although nematode RTK/Ras/ERK com-
ponents at the level of protein-protein interactions or
protein modifications have not been so deeply investigated
as their human counterparts, the canonical pathway seems
to be highly conserved between the nematode and mam-
mals (reviewed in [24]).
Variations of RTK/Ras/ERK signaling in given cell types,
tissues or developmental events use distinct ligands andRTKs, which transmit the signal to the Ras/ERK cytoplas-
mic signaling modul. ERK activation in these processes re-
sults in regulation of different target genes leading to
specification of different cell types and contributing to de-
velopment of different organs. RTK/Ras/ERK signaling
using the ligand LIN-3/EGF and its receptor LET-23/
EGFR initiates vulval induction. The EGFR/Ras/ERK path-
way plays an essential, inductive role during development
of the vulva, the hermaphrodite reproductive organ [25].
Mutations causing reduced Ras signaling (for example
loss-of-function or hypomorph alleles of let-23/EGFR or
let-60/Ras) result in Vulvaless phenotype, whereas in-
creased Ras signaling (for example caused by gain-of-
function alleles of let-23, let-60) leads to a Multivulva
phenotype (reviewed in [24]).
KSR (kinase suppressor of Ras), a well known scaffold
protein of the Ras/MAPK cascade
ksr (kinase suppressor of Ras) genes were initially identi-
fied in C. elegans and Drosophila melanogaster as posi-
tive regulators of Ras/MAPK signaling [26-28].
The Drosophila genome encodes only a single ksr gene
which is essential for viability in the fly [28]. In the worm,
mutations in ksr-1 were isolated in genetic screens search-
ing for suppressors of the Muv (multivulva) phenotype
caused by a gain-of-function allele of let-60/Ras [26,27].
In contrast to its fly counterpart, ksr-1 is not an essential
gene as ksr-1 null mutants are viable and do not show se-
vere defects in development. However, subsequently a sec-
ond ksr ortholog was identified in the nematode genome,
ksr-2 [29]. In the germline Ras/MAPK signaling driven by
an unknown ligand mediates progression of germ cells
through the meiotic pachytene stage [30]. ksr-2 loss-of-
function mutants display a sterile gonad with germ cells
arrested at pachytene, similar to null mutants of other
MAPK cascade genes [29,31].
Inactivation of both worm ksr paralogs, ksr-1 and ksr-2
resulted in “rod-like” L1 lethality and Vulvaless phenotype,
reminiscent of strong let-60/Ras mutant phenotypes, and
revealed that the two ksr paralogs function redundantly in
many processes during worm development and play a key
role in Ras-mediated signaling events [29].
The mouse genome contains two KSR paralogs, KSR1
and KSR2. KSR1 knockout mice are viable and do not dis-
play major developmental defects [32,33], suggesting large
degree of functional redundancy between the different iso-
forms in this organism as well. However in KSR1−/− mice,
as a consequence of decreased MAPK signaling T-cell ac-
tivation is impaired [34], these animals have enlarged adi-
pocytes [35] and are slightly glucose intolerant [32].
Glucose homeostasis is regulated by the MARK2 kinase,
which phosphorylates and inactivates KSR1, thus leading
to dampened ERK signaling [32]. KSR2−/− mice were
found obese and also glucose intolerant [36]. Obesity in
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take and fatty acid oxidation, as KSR2 interacts with
AMPK and modulates its activity [37]. Mutations in KSR-
2 were recently described to be associated with obesity
and insulin resistance in human [38]. It is important to
note that mouse KSR1−/−; KSR2−/− double mutants have
not yet been described.
KSRs are known as scaffold proteins which coordinate
the assembly of membrane-localized Raf/MEK/ERK com-
plexes [39-41]. KSR1 is able to bind all three kinases of
the MAPK pathway: it associates constitutively with MEK,
but interaction with C-Raf and ERK1/2 occurs only upon
growth factor stimulation [39,42]. Thus, upon Ras activa-
tion KSR brings MEK to the plasma membrane in close
proximity to the Raf kinase. In principle, KSR provides a
scaffold, which facilitates the phosphorylation steps in the
MAPK cascade in order to execute signal transduction
downstream of Ras.
The domain structure of KSR proteins is similar to
that of Raf family members indicating their possible
common origin (reviewed in [41]). KSR proteins consist
of five conserved regions, termed CA1–CA5 (summarized
in Figure 1). The N-terminal CA1 domain is unique for
KSRs, this domain was shown to bind Raf in the Drosoph-
ila KSR homolog (reviewed in [43]). The CA2 domain
contains a proline-rich region, whereas the CA3 domain
possess a cysteine-rich region. The CA3 domain is able to
bind lipids, it ensures membrane anchorage of KSR upon
Ras activation, thus this domain regulates the cellular
localization of KSR [44]. The CA4 domain contains a
serine/threonine-rich sequence and conserved sites (FXFP,
Figure 1) for ERK docking [41,45]. Finally, the CA5 do-
main is a C-terminal kinase-like domain, which is similar
to the kinase domain of Raf proteins and seems to be im-
portant for MEK binding [46]. KSR1 is considered to be a
pseudokinase that lacks catalytic activity because of the
absence of an invariant Lys residue in subdomain I, which
is important for orienting ATP in Raf. This critical Lys is
exchanged for Arg in human KSR1, but we note thatFigure 1 Domain organization of the worm KSR proteins related to m
(KSR-specific domain), CA2 (proline-rich region), CA3 (cysteine-rich region),
(C.e.) KSR-1 and KSR-2A lack the CA1 domain. Worm KSR-1 lacks the CA2 dom
docking site) is absent. 14-3-3 binding sites Ser297 (S*) and Ser392 (S* marked
(mKSR1) are absent in the worm proteins.Drosophila KSR and C. elegans KSR-1 (but not KSR-2)
contain Lys in the conserved position. Together, to date
still debates exist about KSR’s catalytic activity.
Recent studies elaborated the mechanism of Raf acti-
vation and highlighted KSR’s function in this process. In
mammalian cells there are three isoforms of Raf: A-Raf,
B-Raf and C-Raf. Recent data suggest that dimerization
plays a key role in Raf activation. Hu and colleagues [47]
showed that Raf dimers are asymmetric, they are com-
posed of an activator kinase (for instance B-Raf) and a
receiver kinase (such as C-Raf). The activator kinase re-
quires no kinase activity but requires N-terminal (NtA:
N-terminal acidic motif ) phosphorylation to allosteri-
cally stimulate cis-autophosphorylation and transactiva-
tion of the partner receiver kinase. KSR can be also
involved in dimerization and Raf activation. If the NtA is
phosphorylated on KSR1 or C-Raf, both can function as ac-
tivator kinases of their partners C-Raf or B-Raf. Moreover,
Brennan and co-workers showed that B-Raf dimerization
with KSR2 could allosterically stimulate the kinase activity
of KSR2 towards MEK [48], however it is not known yet
whether this transactivation event is mediated by the NtA
of B-Raf. Studies on B-Raf inhibitor drugs led to the obser-
vation that unphosphorylated KSR1, however, is able to
block B-Raf activation by constitutively dimerizing with B-
Raf [49]. Thus, KSR represents a critical factor in modula-
tion of the MAPK pathway.
Sequence comparison of the worm KSR proteins re-
veals that C. elegans KSR-1 and KSR-2 share 26% and
31% overall sequence identity with murine KSR1 [18,29].
Genetic analyses show evidences that worm KSR-1 and
KSR-2 are both functional KSR family members [26,27,29],
however differences can be seen in their domain struc-
ture compared with murine KSR1, the best character-
ized mammalian KSR (Figure 1). The CA1 domain is
missing in both C. elegans KSR homologs, in addition,
worm KSR-1 lacks the CA2 domain, whereas in KSR-2
the CA4 domain with the ERK docking site is absent
(Figure 1).urine KSR1. KSR proteins consist of five conserved areas (CA): CA1
CA4 (serine/threonine-rich region), CA5 (kinase-like domain). C. elegans
ain, whereas in KSR-2A the CA4 domain with the FXFP motif (ERK/MAPK
red) located on either side of the CA3 domain in the mouse protein
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to phosphorylate KSR1 on Ser392
Upon Ras activation, KSR1 is localized to the plasma
membrane, but in unstimulated cells KSR can be found
in the cytoplasm. KSR localization is known to be regu-
lated by protein interactions, through phosphorylation
and dephosphorylation steps. In quiescent cells KSR is
phosphorylated on Ser297 and Ser392 residues (residues
are numbered according to the mouse KSR1 sequence),
14-3-3 protein binds to these phosphorylated sites and
keeps KSR in the cytoplasm [42]. 14-3-3 protein is able
to mask the CA3 domain of KSR together with IMP
(impedes of mitogenic signal propagation), an E3 ubi-
quitin ligase, which also binds to the CA3 region of
KSR to inhibit plasma membrane targeting [50].
Growth factor stimulation and Ras activation lead to
multiple changes in the cytosolic KSR complex: Ras
binds to IMP, which is degraded subsequently; upon
growth factor stimulus, the Ser/Thr protein phosphatase
PP2A dephosphorylates KSR1 on the Ser392 residue [51].
As a result, KSR is released of the inhibition exerted by
14-3-3 and translocates to the plasma membrane to pro-
mote MAPK pathway activation.
Phosphorylation and dephosphorylation events occuring
on Ser392 residue are critical in respect of KSR regulation
(Figure 2A). As mentioned above, dephosphorylation of
Ser392 by PP2A results in KSR activation. In contrast,
phosphorylation of this residue for example by the
Cdc25C-associated kinase 1 (C-TAK1) mediates the bind-
ing of KSR to 14-3-3 proteins, driving cytoplasmicFigure 2 Scaffolds of the Raf/MEK/ERK cascade and regulation of KSR
KSR are scaffolds of the Raf/MEK/ERK cascade. SOC-2/SUR-8 and CNK/CNK-1
MEK/ERK complexes and functions downstream of Raf. A) Protein interactio
mammalian KSR, while PP2A is able to dephosphorylate the same residue.
activates KSR-1. NDK-1 activates Ras signaling at the level of KSRs. The mole
be determined. The mammalian proteins and their nematode homologs arsequestration of KSR (i.e. inactivation of KSR) in unstimu-
lated cells [42] (Figure 2A).
C-TAK-1 is not the only kinase phosphorylating KSR
on Ser392 residue. The best known NDPK, human
NM23-H1, which is characterized by histidine protein
kinase activity [54], was also found to phosphorylate one
of the 14-3-3 binding sites of KSR1, Ser392 through a
histidine intermediate [14] (Figure 2A). Overexpression
of NM23-H1 in MDA-MB-435 breast carcinoma cells
resulted in decreased activated MAPK (pMAPK) levels
without affecting the level of total MAPK, suggesting
that NM23-H1 inhibits Ras/MAPK signaling through
KSR phosphorylation and inactivation [14]. In MDA-
MB-435 cells transfected by NM23-H1 increased co-
immunoprecipitation of Hsp90 with KSR1 was observed
[15]. Hsp90 is a binding partner of KSR, which might
promote the proteasome-mediated degradation of KSR,
thus attenuating ERK signaling.
Modulators of KSR activity were also identified in C.
elegans. As EGFR/Ras/ERK activity is indispensable for
vulval induction, differences in the level of MAPK sig-
naling can be measured by scoring the formation of a re-
duced or enhanced number of vulval structures. Thus,
the vulval induction system provides a unique opportunity
to identify regulators of the Ras/ERK cascade. Genetic
epistasis analyses demonstrated that the C-TAK1 homolog
PAR-1 kinase and the worm counterpart of PP2A phos-
phatase, SUR-6/PP2A act downstream of LIN-45/Raf, at
the level of KSR-1 [52,55]. PAR-1 regulated KSR-1 activity
negatively, whereas SUR-6/PP2A modified the effect ofin mammals and in the nematode. SOC-2/SUR-8, CNK/CNK-1 and
are thought to facilitate Raf activation [52,53]. KSR assembles Raf/
ns in mammals [22]. C-TAK1 and Nm23-H1 phosphorylate Ser392 of
B) Genetic interactions in C. elegans. PAR-1 inhibits, while SUR-6/PP2A
cular mechanisms are not known. The regulation of KSR-2 remains to
e labeled by the same color.
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lines [52,55] (Figure 2B). However, as 14-3-3 binding sites
Ser297 and Ser392 are not present in the worm KSR-1
protein (Figure 1), the exact mechanism of action whereby
PAR-1 and SUR-6/PP2A modify KSR activity remains
elusive.
NDK-1, the C. elegans NM23-H1/2 homolog is required for
full activation of Ras/ERK signaling
Our group has recently characterized ndk-1, the C. elegans
ortholog of human nm23-H1/H2 [18]. NDK-1 shows 65%
sequence identity and 85% overall similarity to NM23-H1
and NM23-H2. 50% of ndk-1 loss-of-function mutants die
as embryos, the remainder develop into sterile adults,
which display a protruding vulva (Pvl) phenotype.
The vulva of the C. elegans hermaphrodite develops
from a subset of epidermal blast cells, called vulval pre-
cursor cells (VPCs). Briefly, at the early L3 larval stage
three VPCs, P5.p, P6.p and P7.p receive an inductive sig-
nal conferred by an EGF ligand derived from a specific
cell of the somatic gonad, the anchor cell (Figure 3).
EGF ligand activates the EGFR/Ras/ERK pathway in P
(5–7).p cells (reviewed in [25]). P6.p, the VPC closest to
the anchor cell, adopts the primary vulval fate, while the
neighboring VPCs, P5.p and P7.p adopt the secondaryFigure 3 EGL-17/FGF, a known MAPK target shows reduced expression
develops from a subset of epidermal blast cells, called vulval precursor ce
give rise to 22 vulval cells. The vulva at mid-L4 larval stage is composed o
C, D, E and F). These cells are the great-granddaughters of P5.p-P7.p VPCs (gre
EGL-17/FGF is a known MAPK target, which is expressed in all daughters (P6p
animals. EGL-17/FGF expression was reduced in P6p.xx cells (red triangle) in n
absence of NDK-1 [18].vulval fate as a result of lateral signaling mediated by the
LIN-12/Notch pathway. The induced VPCs undergo
three rounds of cell divisions and finally result in 22 vul-
val cells in the L4 larval stage. P6.p descendants are pri-
mary lineages, whereas descendants of P5.p and P7.p are
secondary vulval cells (Figure 3). These 22 cells undergo
cell migration and fusion events to eventually form the
adult vulval structure (reviewed in [25]). In Pvl mutants
a single protrusion is formed, which is caused by ever-
sion of the vulval tissue [56].
By analyzing the vulva phenotype, we demonstrated
that the number of vulva cells in ndk-1(−) mutants is de-
creased compared with the 22 cells observed in the wild
type. The Pvl phenotype might occur because of misspe-
cification of vulval cell fates, both primary and second-
ary vulval cell fates are affected in the mutants [18].
Next we assessed how NDK-1 modifies Ras/MAPK sig-
naling. egl-17/FGF is a known MAPK target, which is
expressed in primary vulval lineages during L3 larval
stage [57]. We observed a reduced egl-17/FGF expres-
sion in P6.p granddaughter cells in the developing vulval
tissue of ndk-1 mutants (Figure 3). Epistasis analysis per-
formed with ndk-1 and Ras pathway mutants demon-
strated that ndk-1 acts downstream of lin- 45/Raf and
upstream of mek-2/MEK and mpk-1/MAPK to affect thein ndk-1(−) mutant background. The vulva of wild-type hermaphrodites
lls (VPCs). P(5–7).p VPCs undergo three rounds of cell division and
f 22 cells, which can be grouped into seven cell types (vulA, B1, B2,
y filled circles: primary lineages; white circles: secondary lineages).
.x) and granddaughters (P6p.xx) of P6.p in the L3 stage in wild-type
dk-1(−) mutants suggesting that Ras/MAPK signaling is inhibited in the
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a strongly decreased level of activated MAPK in somatic
tissues of ndk-1 knockouts, whereas total MAPK levels
were comparable with wild-type animals [18]. Together,
these results show that NDK-1 is necessary for proper
MAPK activation in somatic tissues of the worm. Since
NDK-1 and the KSR paralogs function at the same level
in the Ras/ERK cascade and they all contribute to
MAPK activation, we generated ndk-1(−);ksr-1(−) and
ndk-1(−)ksr-2(−) double knockouts in order to test their
potential genetic interactions. In the double mutants en-
hancement of single-mutant phenotypes was observed,
in particular in case of ndk-1(−)ksr-2(−), where embry-
onic lethality of homozygous ndk-1(−) mutants (50%)
becomes fully penetrant. The complete lethality of ndk-1
(−)ksr-2(−) double mutants suggest that NDK-1 and
KSR-2 display essential functions during C. elegans em-
bryogenesis. In vitro pulldown experiments showed that
NDK-1 binds to worm KSR-2 and murine KSR1.
Conclusions
In the human breast carcinoma cell line MDA-MB435
and in HEK293 cells NM23-H1 has been shown to
phosphorylate KSR1 on Ser392 [14,15,17], and NM23-
H1 overexpression in those cells resulted in reduced
levels of MAPK signaling. Conversely, silencing of
NM23-H1 in HepG2 hepatocellular carcinoma cells in-
duced elevated phospho-ERK levels [8]. It was also sug-
gested that increased levels of NM23-H2 block the ERK
pathway [16]. Thus, NDPKs might attenuate Ras/ERK
signaling through phosphorylation (thus inactivation) of
KSR scaffolds.
Our group has recently characterized NDK-1, the C.
elegans homolog of group I NDPKs, and we provided a
compelling case that NDK-1 affects Ras/MAPK signaling
at the level of KSRs, and first demonstrated a functional
interaction between NDK-1/NDPK and KSRs in vivo
[18]. However, genetic and biochemical data demon-
strate reduced MAPK signaling in somatic tissues of
ndk-1 knockouts, therefore we conclude that NDK-1 is
necessary for proper MAPK activation, thus NDK-1/
NDPK exerts a stimulatory effect on Ras/MAPK signal-
ing [18]. Since NDK-1 directly interacts with KSR-2 and
with murine KSR1, we consider it likely that NDK-1
modifies the function of KSR scaffolds.
Contradictions between mammalian and C. elegans
data regarding the effect of NDPKs on the outcome of
Ras/ERK signaling could be resolved if we better under-
stand the function and regulation of KSR scaffolds.
Mouse KSR1 harbors 14-3-3 binding sites Ser297 and
Ser392 that are involved in KSR scaffold regulation in
mammals [42]. The implicated residues, however, are
evolutionary not conserved in C. elegans KSR proteins
(Figure 1) [29], suggesting that a 14-3-3 domain bindingtriggered attenuation may not be operating in the worm.
Genetic data demonstrate that the C-TAK1 homolog
PAR-1 kinase and SUR-6/PP2A phosphatase are involved
in the regulation of worm KSR-1 similar to their human
counterparts, but the exact KSR-1 residues where PAR-1
and SUR-6/PP2A act, are not known (Figure 2) [52,55].
Worm KSR-2 seems to be the most divergent member of
the KSR family, as it lacks the CA1 region and the CA4
domain, which contains the ERK docking site (Figure 1)
[29]. Therefore, it is possible that KSR-2 might function
differently from other KSR proteins, and its regulation
might involve other mechanisms. It is also important to
consider that Raf activation might occur differently in the
worm compared to mammals, as in C. elegans only B-Raf
(LIN-45) is present but not C-Raf [24]. Novel studies sug-
gest that dimerization involving KSR is crucial for Raf acti-
vation, in addition unphosphorylated KSR might exert an
inhibitory effect on Raf activation [47-49]. Not only the
phosphorylation status of KSR, but also its expression
level might be important regarding the outcome of MAPK
signaling, as early studies on overexpression of mamma-
lian KSR pointed to a negative role for KSR in signaling,
while later loss-of-function studies suggested a positive
role (reviewed in [39]).
Together, further studies are necessary to dissect the
molecular mechanism by which NDK-1 influences KSR
activity. These studies could provide further data about
regulation of scaffolds, as scaffolds are known to act not
only as passive signaling platforms, but active surfaces,
whose changes might significantly influence the outcome
of signaling [58].
KSRs might also function differently in distinct organ-
isms. In the worm KSR activity is indispensable for Ras
signaling, as inactivation of both ksr paralogs by RNAi
results in L1 lethality (e.g. strong ras-like phenotype)
and absent levels of activated MAPK [29]. In contrast,
in KSR-1 knockout mice the high molecular weight
complexes containing KSR, MEK and ERK are not as-
sembled, although the mutants are grossly normal [34].
These data suggest that mouse KSR1 is not strictly re-
quired for, but rather enhances MAPK signaling. How-
ever, to date there are no data available about the
phenotype and activated MAPK levels of KSR1−/−;
KSR2−/− double mutant mice.
Recently pioneering work has shown that in HEK293
cells RGS19 (regulator of G protein signaling 19) is able
to suppress Ras signaling through upregulation of Nm23
expression and NM23-mediated phosphorylation of KSR
[17]. KSR and Nm23 were also linked to G protein sig-
naling [59,60]. RGS19 is classified as a member of the
RZ/A subfamily of RGS proteins [61]. This subfamily is
also represented in the worm by RGS-1 and RGS-2 al-
though they lack an N-terminal cysteine string, which is
present in human family members [62,63]. Further
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http://www.jmolecularsignaling.com/content/9/1/4investigations are necessary to explore, whether the func-
tion of C. elegans RGS-1 and RGS-2 is related to the
NDK-1/KSR interaction, and to see how transcriptional
activation of ndk-1/nm23 is regulated. Nevertheless, muta-
genesis screens could be performed in C. elegans in order
to identify upstream regulators of ndk-1/nm23.
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